Cohort PLC
F:C7K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cohort PLC
F:C7K
|
UK |
|
U
|
United Overseas Bank Ltd
XMUN:UOB
|
SG |
|
P
|
PharmaSGP Holding SE
XMUN:PSG
|
DE |
|
Molecular Templates Inc
OTC:MTEM
|
US |
Wall St Price Targets
C7K Price Targets Summary
Cohort PLC
According to Wall Street analysts, the average 1-year price target for
C7K is 20.4 EUR with a low forecast of 16.89 EUR and a high forecast of 23.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C7K's stock price target?
Price Target
20.4
EUR
According to Wall Street analysts, the average 1-year price target for
C7K is 20.4 EUR with a low forecast of 16.89 EUR and a high forecast of 23.81 EUR.
What is the Revenue forecast for Cohort PLC?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 9%.
What is the Gross Profit forecast for Cohort PLC?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 11%.
What is the Operating Income forecast for Cohort PLC?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 4 years is 20%.
What is the Pre-Tax Income forecast for Cohort PLC?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Cohort PLC?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 4 years is 20%.